Heartscape Technologies, Inc. is a privately held venture funded company engaged in the development and marketing of the PRIME ECGÂ® System (PRIME), a breakthrough medical device that is designed to allow more accurate and rapid diagnosis of heart attacks (acute myocardial infarction or AMI) and ischemia. PRIME is a patented, FDA approved product with an annual US market opportunity of approximately $1 billion.

Recent Milestones
edit

Heartscape received $17M (£8.49M) in Series B funding. (4/24/07)

Posted 3/13/09 at 8:27am via allbusiness.com
Heartscape added Donald Foscato as Chief Financial Officer.

Posted 3/13/09 at 8:27am
Heartscape added Paul Curley as Vice President Marketing.

Posted 3/13/09 at 8:27am
Heartscape added Carl Rebert as President and COO.

Posted 3/13/09 at 8:27am
Heartscape added Arthur Hiller as CEO.

Posted 3/13/09 at 8:27am
Heartscape added Kim Hillis as Vice President Sales.

Posted 3/13/09 at 8:27am